ELMD logo

ELECTROMED INC

ELMDNYSE AMERICAN
πŸ† #2810 by market capEarnings Aug 25US Equity
$42.43β–² $0.04 (+0.09%)
Live
1hβ€”
24hβ–² 0.1%
7dβ–² 1.8%
14dβ–² 5.4%
30dβ–Ό 8.4%
1yβ–² 119.5%
🏦Market Cap
$351M
Small Cap
πŸ“ˆRevenue Growth (YoY)
+17.0%
Healthy
πŸ“ŠGross Margin
78.4%
High
πŸ’΅FCF Margin
14.3%
Healthy
βš–οΈP/S Ratio
4.9x
Fair
Otter Score
50
Weak

Trading Snapshot

Day Range
$42.13 – $42.90
52-Week Range
$18.81 – $47.40
Volume
$2.05B
Avg Volume
$2.12B
Shares Outstanding
8.3M
Next Earnings
Sep 20, 2026

Fundamentals Snapshot

Annual Revenue
$64M
Last Q Revenue
$19M
P/E Ratio
34.8
P/S Ratio
4.9x
EPS (TTM)
$1.23
Dividend Yield
0.00%

Why Investors Own ELMD

  • βœ“High-growth profile β€” revenue up +49.3% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 61% gross margin and 18% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$64Mβ–² +56.0% YoY
Gross Margin (TTM)
60.9%β–² +2.6% YoY
Operating Income (TTM)
$13Mβ–² +56.0% YoY
Free Cash Flow (TTM)
$11Mβ–² +56.0% YoY

About ELECTROMED INC

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
50/100

Analyst Ratings

β“˜
Consensus
Buy
9 analysts
Strong Buy2
Buy6
Hold1
Sell0
Strong Sell0
Ratings as of Aug 2026

Latest News & Updates